☆ 4.7 Article

Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease

CLINICAL INFECTIOUS DISEASES (2023)

Related references

Note: Only part of the references are listed.

Review Medicine, Research & Experimental

Phage Therapy for Antibiotic-Resistant Bacterial Infections

Graham F. Hatfull et al.

Summary: Antibiotic resistance in bacterial pathogens poses a significant threat to disease control. The use of bacteriophages as therapeutic agents has regained interest due to recent clinical successes. However, challenges such as strain variation, phage resistance, and potential limitations of host immune responses need to be addressed.

ANNUAL REVIEW OF MEDICINE (2022)

Add to Collection

Article Critical Care Medicine

Treatment of Mycobacterium abscessus Pulmonary Disease

David E. Griffith et al.

Summary: Mycobacterium abscessus, a common pathogen in nontuberculous mycobacterial lung diseases, has different subspecies with varying drug susceptibilities. Macrolides and amikacin are commonly used drugs, but their efficacy is limited against resistant strains. New drugs show promising in vitro activity, but further validation is needed.

CHEST (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection

Jerry A. Nick et al.

Summary: This study describes a successful phage treatment of treatment-refractory Mycobacterium abscessus pulmonary infection in a patient with severe lung disease. The phages used in the treatment were engineered to enhance their ability to lyse M. abscessus and were specifically selected based on their effectiveness against the patient's bacterial isolate. The treatment resulted in genetic stability of the bacterial isolate and improved clinical symptoms in the patient.

CELL (2022)

Add to Collection

Article Multidisciplinary Sciences

Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection

Jessica S. Little et al.

Summary: The use of bacteriophage in combination with antimicrobial therapy was effective in improving disease response in a patient with multidrug-resistant M. chelonae infection. Despite the development of neutralizing antibodies against the bacteriophage, the patient continued to show stable improvement with no evidence of bacterial resistance to the phage.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Microbiology

Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance

Rebekah M. Dedrick et al.

Summary: Mycobacterium abscessus is an opportunistic pathogen with widespread multidrug resistance, making treatment difficult. However, the use of bacteriophages has shown potential as an alternative approach, especially for rough strains. Studying the phage infection profiles of clinical isolates has revealed that colony morphotype is a key indicator of phage susceptibility, leading to the possibility of using small cocktails or single phages for controlling infections.

MBIO (2021)

Add to Collection

Article Microbiology

The Prophage and Plasmid Mobilome as a Likely Driver of Mycobacterium abscessus Diversity

Rebekah M. Dedrick et al.

Summary: The study shows that prophages and plasmids play a significant role in the pathogenicity and antibiotic susceptibility of Mycobacterium abscessus by influencing a variety of virulence-related genes. Understanding this diversity can facilitate a better comprehension of the characteristics of M. abscessus.

MBIO (2021)

Add to Collection

Article Microbiology

Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains

Carlos A. Guerrero-Bustamante et al.

Summary: Research suggests using bacteriophages may be a promising strategy for treating tuberculosis, with a five-phage cocktail effectively killing Mycobacterium tuberculosis strains without affecting antibiotic effectiveness. This offers new possibilities for treating tuberculosis and combating antibiotic resistance.

MBIO (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection

Rebekah M. Dedrick et al.

Summary: In a case study, it was found that bacteriophage therapy was effective in reducing the infectious burden of a refractory bacterial infection in an immunocompetent patient, but its efficacy was limited as the patient developed neutralizing antibodies against the phages after two months.

NATURE MEDICINE (2021)

Add to Collection

Article Pediatrics

Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis

Stacey L. Martiniano et al.

PEDIATRIC PULMONOLOGY (2020)

Add to Collection

Article Immunology

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline

Charles L. Daley et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Article Immunology

Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States

Saima Aslam et al.

OPEN FORUM INFECTIOUS DISEASES (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

Rebekah M. Dedrick et al.

NATURE MEDICINE (2019)

Add to Collection

Review Critical Care Medicine

Nontuberculous Mycobacteria in Cystic Fibrosis

Christopher J. Richards et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Add to Collection

Article Microbiology

A Rapid Unraveling of the Activity and Antibiotic Susceptibility of Mycobacteria

A. Mustazzolu et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

Add to Collection

Article Infectious Diseases

Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial

Patrick Jault et al.

LANCET INFECTIOUS DISEASES (2019)

Add to Collection

Article Evolutionary Biology

Phage treatment of an aortic graft infected with & IT;Pseudomonas aeruginosa & IT;

Benjamin K. Chan et al.

EVOLUTION MEDICINE AND PUBLIC HEALTH (2018)

Add to Collection

Article Microbiology

Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection

Robert T. Schooley et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

Add to Collection

Article Medicine, General & Internal

Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh

Shafiqul Alam Sarker et al.

EBIOMEDICINE (2016)

Add to Collection

Review Critical Care Medicine

Nontuberculous Mycobacteria in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis

In Kwon Park et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Add to Collection

Article Microbiology

Characterization of Rough and Smooth Morphotypes of Mycobacterium abscessus Isolates from Clinical Specimens

Kai Rueger et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2014)

Add to Collection

Review Immunology

Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-γ immunity

Jacinta Bustamante et al.

SEMINARS IN IMMUNOLOGY (2014)

Add to Collection

Article Microbiology

Mycobacteriophages: Windows into Tuberculosis

Graham F. Hatfull

PLOS PATHOGENS (2014)

Add to Collection

© Peeref 2019-2024. All rights reserved.